3-dimethylamino-2-methyl-N,N-dimethylbenzamide | 203628-40-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-dimethylamino-2-methyl-N,N-dimethylbenzamide
• 英文别名: 3-dimethylamino-2,N,N-trimethylbenzamide；3-(dimethylamino)-N,N,2-trimethylbenzamide
• CAS: 203628-40-4
• 化学式: C₁₂H₁₈N₂O
• 分子量: 206.288
• InChiKey: LZYFAJJSBYPNMA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  23.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-dimethylamino-2-methyl-N,N-dimethylbenzamide 在 lithium diisopropyl amide 、 三氯氧磷 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 4.0h， 生成 1-chloro-5-dimethylamino-3-(4-chlorophenyl)isoquinoline
  参考文献：
  名称：

  Synthesis and comparative molecular field analysis (CoMFA) of antitumor 3-arylisoquinoline derivatives

  摘要：

  In this study a series of 3-arylisoquinoline derivatives were synthesized and cytotoxicity against human melanoma tumor cell evaluated, and a three dimensional quantitative structure-activity relationship was investigated using the comparative molecular field analysis (CoMFA). The results suggested that the electrostatic, steric and hydrophobic factors of 3-arylisoquinolines were strongly correlated with the antitumor activity. Considerable predictive ability (cross-validated r(2) as high as 0.721) was obtained through CoMFA, (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(98)80019-9
• 作为产物：
  描述：

  聚合甲醛 、 3-amino-N,N,2-trimethylbenzamide 在 sodium cyanoborohydride 、 zinc(II) chloride 作用下， 以 甲醇 、 水 为溶剂， 以99%的产率得到3-dimethylamino-2-methyl-N,N-dimethylbenzamide
  参考文献：
  名称：

  Synthesis and comparative molecular field analysis (CoMFA) of antitumor 3-arylisoquinoline derivatives

  摘要：

  In this study a series of 3-arylisoquinoline derivatives were synthesized and cytotoxicity against human melanoma tumor cell evaluated, and a three dimensional quantitative structure-activity relationship was investigated using the comparative molecular field analysis (CoMFA). The results suggested that the electrostatic, steric and hydrophobic factors of 3-arylisoquinolines were strongly correlated with the antitumor activity. Considerable predictive ability (cross-validated r(2) as high as 0.721) was obtained through CoMFA, (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(98)80019-9

文献信息

• 5, 6, or 7-Substituted - 3-(hetero) arylisoquinolinamine derivatives and therapeutic use thereof
  申请人：Lee Young B.

  公开号：US20080182871A1

  公开（公告）日：2008-07-31

  The present invention relates to 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives represented by general formula D, their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by administering the compounds are also included.

  本发明涉及一般公式D所代表的5,6或7-取代-3-(杂)芳基异喹啉胺衍生物及其药理学上可接受的盐，以及含有这类化合物的组合物。还包括通过给予这些化合物来治疗过度增殖性疾病的方法。
• 5, 6, or 7-SUBSTITUTED -3-(HETERO) ARYLISOQUINOLINAMINE DERIVATIVES AND THERAPEUTIC USE THEREOF
  申请人：LEE YOUNG B.

  公开号：US20120029012A1

  公开（公告）日：2012-02-02

  The present invention relates to 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives represented by general formula D, their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by administering the compounds are also included.

  本发明涉及5、6或7-取代-3-(杂)芳基异喹啉胺衍生物D的一般式，其药理学上可接受的盐以及含有这种化合物的组合物。还包括通过给予这些化合物治疗过度增殖性疾病的方法。
• 5, 6 or 7-substituted-3-phenylisoquinolinamine derivatives and therapeutic use thereof
  申请人：Rexahn Pharmaceuticals, Inc.

  公开号：EP2423196A1

  公开（公告）日：2012-02-29

  The present invention relates to 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives represented by general formula D, their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative disorders by administering the compounds are also included.

  本发明涉及通式 D 所代表的 5、6 或 7-取代-3-(杂)芳基异喹啉胺衍生物、其药理学上可接受的盐，以及含有此类化合物的组合物。此外，还包括通过施用这些化合物来治疗过度增殖性疾病的方法。
• Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents
  作者：Won-Jea Cho、Myun-Ji Park、Byung-Ho Chung、Chong-Ok Lee

  DOI：10.1016/s0960-894x(97)10190-1

  日期：1998.1

  To investigate the structure-activity relationship of 7,8-dimethoxy-2-methyl-3-(4,5-methylenedioxy-2-vinylphenyl)isoquinolin-1(2H)-one 2, diverse substituted 3-arylisoquinolines were synthesized and tested in vitro antitumor activity against five human tumor cell lines. The results showed a broad antitumor spectrum for a series of 3-arylisoquinolines. (C) 1997 Elsevier Science Ltd. All rights reserved.
• 5, 6, OR 7-SUBSTITUTED-3-(HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS
  申请人：Rexahn Pharmaceuticals, Inc.

  公开号：EP2099765A2

  公开（公告）日：2009-09-16